Novabio
Laboratory Services (Healthcare)
Novabio valuation and funding history | Last updated: January 22, 2026 | 1 funding rounds
Current Valuation
N/A
As of January 22, 2026
Total Funding Raised
N/A
Across 1 round
Last Round
Buyout/LBO (Add-on)†
Amount undisclosed
Last Funding
Jan 2026
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| January 22, 2026 | Buyout/LBO (Add-on)† | Undisclosed | N/A | - |
Valuation Analysis
Current Valuation Metrics
Novabio is currently valued at N/A as of January 22, 2026.
What is Novabio Worth in 2026?
Novabio is a leading private company in the Laboratory Services (Healthcare) sector. Track Novabio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Novabio Valuation is Determined
Private company valuations like Novabio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.